Literature DB >> 12370388

Differences between T cell epitopes recognized after immunization and after infection.

Thorsten U Vogel1, Helen Horton, Deborah H Fuller, Donald K Carter, Kathy Vielhuber, David H O'Connor, Tim Shipley, Jim Fuller, Gerd Sutter, Volker Erfle, Nancy Wilson, Louis J Picker, David I Watkins.   

Abstract

Evidence suggests that cellular immune responses play a crucial role in the control of HIV and SIV replication in infected individuals. Several vaccine strategies have therefore targeted these CD8(+) and CD4(+) responses. Whether vaccination induces the same repertoire of responses seen after infection is, however, a key unanswered question in HIV vaccine development. We therefore compared the epitope specificity induced by vaccination to that present postchallenge in the peripheral blood. Intracellular cytokine staining of PBMC stimulated with overlapping 15/20-mer peptides spanning the proteins of SIV were measured after DNA/modified vaccinia Ankara vaccination of eight rhesus macaques. Lymphocytes from 8 animals recognized a total of 39 CD8 epitopes and 41 CD4 epitopes encoded by the vaccine. T cell responses were again monitored after challenge with SIVmac239 to investigate the evolution of these responses. Only 57% of all CD8(+) T cell responses and 19% of all CD4(+) T cell responses present after vaccination were recalled after infection as measured in the peripheral blood. Interestingly, 29 new CD8 epitopes and 5 new CD4 epitopes were recognized by PBMC in the acute phase. These new epitopes were not detected after vaccination, and only some of them were maintained in the chronic phase (33% of CD8 and no CD4 responses). Additionally, 24 new CD8 epitopes and 7 new CD4 epitopes were recognized by PBMC in the chronic phase of infection. The repertoire of the immune response detected in the peripheral blood after immunization substantially differed from the immune response detected in the peripheral blood after infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370388     DOI: 10.4049/jimmunol.169.8.4511

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques.

Authors:  Adrian B McDermott; David H O'Connor; Sarah Fuenger; Shari Piaskowski; Sarah Martin; John Loffredo; Matthew Reynolds; Jason Reed; Jessica Furlott; Timothy Jacoby; Cara Riek; Elizabeth Dodds; Kendall Krebs; Mary-Ellen Davies; William A Schleif; Danilo R Casimiro; John W Shiver; D I Watkins
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Repertoire of HLA-DR1-restricted CD4 T-cell responses to capsular Caf1 antigen of Yersinia pestis in human leukocyte antigen transgenic mice.

Authors:  Julie A Musson; Rebecca Ingram; Guillaume Durand; Stephanie Ascough; Emma L Waters; M Gillian Hartley; Timothy Robson; Bernard Maillere; E Diane Williamson; Shiranee Sriskandan; Daniel Altmann; John H Robinson
Journal:  Infect Immun       Date:  2010-07-26       Impact factor: 3.441

Review 3.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

4.  The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers.

Authors:  Juan P Giraldo-Vela; Richard Rudersdorf; Chungwon Chung; Ying Qi; Lyle T Wallace; Benjamin Bimber; Gretta J Borchardt; Debra L Fisk; Chrystal E Glidden; John T Loffredo; Shari M Piaskowski; Jessica R Furlott; Juan P Morales-Martinez; Nancy A Wilson; William M Rehrauer; Jeffrey D Lifson; Mary Carrington; David I Watkins
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

5.  Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses.

Authors:  David H O'Connor; Bianca R Mothe; Jason T Weinfurter; Sarah Fuenger; William M Rehrauer; Peicheng Jing; Richard R Rudersdorf; Max E Liebl; Kendall Krebs; Joshua Vasquez; Elizabeth Dodds; John Loffredo; Sarah Martin; Adrian B McDermott; Todd M Allen; Chenxi Wang; G G Doxiadis; David C Montefiori; Austin Hughes; Dennis R Burton; David B Allison; Steven M Wolinsky; Ronald Bontrop; Louis J Picker; David I Watkins
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.

Authors:  R Draenert; C L Verrill; Y Tang; T M Allen; A G Wurcel; M Boczanowski; A Lechner; A Y Kim; T Suscovich; N V Brown; M M Addo; B D Walker
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants.

Authors:  Jennifer A Slyker; Barbara L Lohman; Dorothy A Mbori-Ngacha; Marie Reilly; Edmund G-T Wee; Tao Dong; Andrew J McMichael; Sarah L Rowland-Jones; Tomas Hanke; Grace John-Stewart
Journal:  Vaccine       Date:  2005-02-19       Impact factor: 3.641

8.  Natural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokines.

Authors:  Rebecca J Ingram; Stephanie Ascough; Catherine J Reynolds; Gökhan Metan; Mehmet Doganay; Les Baillie; Diane E Williamson; John H Robinson; Bernard Maillere; Rosemary J Boyton; Daniel M Altmann
Journal:  Cell Biosci       Date:  2015-04-26       Impact factor: 7.133

9.  Macaques vaccinated with live-attenuated SIV control replication of heterologous virus.

Authors:  Matthew R Reynolds; Andrea M Weiler; Kim L Weisgrau; Shari M Piaskowski; Jessica R Furlott; Jason T Weinfurter; Masahiko Kaizu; Taeko Soma; Enrique J León; Caitlin MacNair; Dan P Leaman; Michael B Zwick; Emma Gostick; Solomon K Musani; David A Price; Thomas C Friedrich; Eva G Rakasz; Nancy A Wilson; Adrian B McDermott; Rosanne Boyle; David B Allison; Dennis R Burton; Wayne C Koff; David I Watkins
Journal:  J Exp Med       Date:  2008-10-06       Impact factor: 14.307

Review 10.  Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery.

Authors:  Sergio C F Mendonça
Journal:  Parasit Vectors       Date:  2016-09-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.